APHTON CORP
SC 13D, 1996-09-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: APHTON CORP, 10-Q, 1996-09-12
Next: APHTON CORP, SC 13D, 1996-09-12



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                            (Amendment No. ________)*

                               APHTON CORPORATION
                                (Name of Issuer)

                           Common Stock (no par value)
                         (Title of Class of Securities)

                                                    03759P-10-1
                                 (CUSIP Number)

                  Fred Jacobs, PO Box 1049, Woodland, CA 95776, 916-661-6077
     (Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)

                               September 12, 1996
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box.

Check the  following  box if a fee is being paid with the statement X. (A fee is
not required only if the reporting person:  (1) has a previous statement on file
reporting  beneficial  ownership  of more  than  five  percent  of the  class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.)

     Note: Six copies of this statement, including all exhibits, should be filed
with the  Commission.  See Rule 13d-1(a) for other parties to whom copies are to
be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).


                                  SCHEDULE 13D

CUSIP No. 03759P-10-1                                         Page 1 of 1 Pages

1        NAME OF REPORTING PERSON
         S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
                  ELIEZER BENJAMINI

2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*         (a)
                                                                   (b)

3        SEC USE ONLY

4        SOURCE OF FUNDS*
                  PF

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
               2(d) OR 2(e)

6        CITIZENSHIP OR PLACE OF ORGANIZATION
                  UNITED STATES OF AMERICA

                                 7        SOLE VOTING POWER
           NUMBER OF                               741,750
            SHARES
         BENEFICIALLY            8        SHARED VOTING POWER
           OWNED BY                                0
             EACH
           REPORTING             9        SOLE DISPOSITIVE POWER
            PERSON                                 741,750
             WITH
                                 10       SHARED DISPOSITIVE POWER
                                                   0

11       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                  741,750

12       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13       PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                  5.7%

14       TYPE OF REPORTING PERSON*
                  IN

*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE  BOTH  SIDES  OF THE  COVER  PAGE,  RESPONSES  TO ITEMS  1-7  (INCLUDING
EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.

         After reasonable  inquiry and to the best of my knowledge and belief, I
certify that the information  set forth in this statement is true,  complete and
correct.

Date:  September 12, 1996                    Signature:  /s/ Eliezer Benjamini
                                                              Name/Title



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission